AU Patent

AU2001273290B2 — Core formulation comprising troglitazone and a biguanide

Assigned to Kos Life Sciences Inc · Expires 2004-10-07 · 22y expired

What this patent protects

Patent listed against metformin-hydrochloride.

Drugs covered by this patent

metformin-hydrochloride (METFORMIN HYDROCHLORIDE)

Patent Metadata

Patent number: AU2001273290B2
Jurisdiction: AU
Classification: —
Expires: 2004-10-07
Drug substance claim: No
Drug product claim: No
Assignee: Kos Life Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.